GFAP Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of GFAP Antibodies for research in glial fibrillary acidic protein studies. Monoclonal GFAP Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GFAP is a key intermediate filament protein expressed in astrocytes and plays a crucial role in maintaining the structural integrity of the central nervous system. As a marker for astrocyte activation in response to injury or disease, GFAP serves as an essential target for studying neuroinflammatory processes and neurodegenerative disorders. Understanding GFAP's function advances research in neurological diseases and supports the development of potential therapeutic strategies. Monoclonal GFAP Antibodies enable precise detection and analysis of astrocyte responses in various neurological conditions. Researchers can utilize GFAP Antibodies to investigate cellular mechanisms involved in brain injury, inflammation, and repair processes. The high specificity of monoclonal GFAP Antibodies from Santa Cruz Biotechnology helps researchers worldwide advance our understanding of neurological diseases and potential treatments.